4 Senior Executives Are Leaving Sanofi Following New CEO's Strategic OverhaulThe Motley Fool • 02/11/20
Sanofi's Acquisition Enhances Its Immuno-Oncology Pipeline With Potential Game-Changing ProductSeeking Alpha • 12/23/19
Biotech Stocks Burn A Hole In Big Pharma's Pocket. Look For More In 2020Investors Business Daily • 12/13/19
Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for BothThe Motley Fool • 12/10/19
Regeneron Shares Swing On Sanofi's Hint At Sale Of Ownership Stake, Amendments To Drug CollaborationsBenzinga • 12/10/19